Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Garcia, Jean Michel ^a   Pepin, Stephanie ^b   Lagarde, Nadège ^a   Ma, Edward S K ^c   Vogel, Frederick R ^b   Chan, Kwok H ^c   Chiu, Susan S S ^c   Peiris, J S M ^a,c  

^a HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

^b SANOFI PASTEUR   (France)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; VIRUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MAJOR CLINICAL STUDY; SEASONAL VARIATION; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; DOG; EUROPE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SERODIAGNOSIS; VIROLOGY;

INFLUENZA A VIRUS;

AGED; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHILD; DOGS; EUROPE; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; NEURAMINIDASE; NEUTRALIZATION TESTS;

EID: 71049124869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007918     Document Type: Article

References (31)

1. Schulman JL, Kilbourne ED (1965) Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus. J Bacteriol 89: 170-174.
2. Yetter RA, Barber WH, Small PA (1980) Heterosubtypic immunity to influenza in ferrets. Infect Immun 29: 650-653.
3. Heinen PP, de Boer-Luijtze EA, Bianchi ATJ (2001) Respiratory and systemic humoral and cellular immune response of pigs to heterosubtypic influenza A virus infection. J Gen Virol 82: 2697-2707.
4. Seo SH, Webster RG (2001) Cross-reactive, cell mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75: 2516-2525.
5. Epstein SL (2003) Control of influenza virus infection by immunity to conserved viral features. Expert Rev Anti Infect Ther 1: 627-638.
6. Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, et al. (2007) Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 196: 1313-1320.
7. Slepushkin AN (1959) The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull Word Health Organ 20: 297-301.
8. Epstein SL (2006) Prior H1N1 influenza infection and susceptibility of Cleveland family study participants during the H2N2 pandemic of 1957: An experiment of Nature. J Infect Dis 193: 49-53.
9. Grebe KM, Yewdell JW, Bennink JR (2008) Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect 10(9): 1024-1029.
10. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, et al. (2007) Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4: e59. doi:10.1371/journal.pmed.0040059.
11. Stephenson I, Nicholson KG, Glück R, Mischler R, Newman RW, et al. (2003) Safety and antigenicity of whole virus and subunit influenza A/ Hong Kong/ 1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 362: 1959-1966.
12. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354(13): 1343-1351.
13. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3: e3942. doi:10.1371/journal.pone.0003942.
14. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody Recognition of a Highly Conserved Influenza Virus Epitope. Science;DOI: 10.1126/science.1171491.
15. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16(3): 265-273.
16. Garcia JM, Fries K, Lagarde N, Ma ESK, Buchy P, et al. Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle - based serological assay. J Clin Virol. In press.
17. Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL (2007) Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 119(6): 1076-1082.
18. Hui SL, Chu LW, Peiris JSM, Chan KH, Chu D, et al. (2006) Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 24: 5371-5380.
19. Nefkens I, Garcia JM, Lagarde N, Chu K, Peiris M, et al. (2007) Hemagglutinin pseudotyped lentiviral particles: Characterization of a new tool for avian influenza H5N1 influenza serodiagnostic. J Clin Virol 39: 27-33.
20. Hill AV (1910) The possible effects of aggregation of the molecules of hemoglobin on its dissociation curves. J Physiol (Lond.) 40: 4-7.
21. Choi YK, Nguyen TD, Ozaki H, Webby RJ, Puthavathana P, et al. (2005) Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol 79: 10821-10825.
22. Bresson JL, Perronne C, Launay O, Gerdil C, Saville M, et al. (2006) Safety and immunogenicity of an inactivated split-virion influenza A/ Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 367: 1657-1664.
23. Levie K, Leroux-Roels I, Hoppenbrouwers K, Kervyn AD, Vandermeulen C, et al. (2008) An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. J Infect Dis 198(5): 642-649.
24. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, et al. (1999) Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 180: 1763-1770.
25. Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, et al. (2008) Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE 3: e2517. doi:10.1371/journal.pone.0002517.
26. Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, et al. (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6: e1000049. doi:10.1371/ journal.pmed.1000049.
27. Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, et al. (2009) Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. Plos Pathogens 5: e1000350. doi:10.1371/journal.ppat.1000350.
28. Wang TT, Palese P (2009) Universal epitopes of influenza virus hemagglutinins? Nat Struct Mol Biol 16(3): 233-234.
29. Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, et al. (2008) Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci USA 105: 5986-5991.
30. Vong S, Coghlan B, Sek M, Holl D, Seng H, et al. (2006) Low frequency of poultry-to-human H5N1 virus transmission, Southern Cambodia, 2005. Emerg Inf Dis 12: 1542-1547.
31. WHO. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358: 261-273.